Background: Directly Observed Treatment Short-course (DOTS) has been one of the major strategies to combat the epidemic of tuberculosis (TB) globally. This study aimed to evaluate TB treatment outcomes between September 2004 and July 2014 under the DOTS program at one of the largest public hospitals in Ethiopia.
Methods: A retrospective data of TB patients registered at Asella Teaching Hospital between September 2004 and July 2014 were obtained from hospital registry. Treatment outcomes and types of TB cases were categorized according to the national TB control program guideline. Binomial and multinomial logistic regression models were used to analyze the association between treatment outcomes and potential predictor variables.
results: A total of 1,755 TB patients' records were included in the study. Of these, 945 (53.8%) were male, 480 (27.4%) smear-positive TB, 287 (16.4%) HIV positive, and 1,549 (88.3%) new cases. Among 480 smear-positive pulmonary TB cases, 377 (78.5%) patients were cured, 21 (4.40) completed the treatment, 35 (7.3%) transferred out, 19 (4.0%) died, 24 (5.0%) defaulted, and 4 (0.8%) failure. Overall, 398 (82.9%) smear-positive pulmonary TB patients were successfully treated. For smear-negative TB (n = 641) and extrapulmonary TB cases (n = 634), 1,036 (81.3%) completed the treatment and demonstrated favorable response. Taking all TB types into account, 1,434 (81.7%) were considered as successfully treated. In the multivariate binary logistic model, patients in older age group (AOR = 0.386, 95% CI: 0.250-0.596) and retreatment cases (AOR = 0.422, 95% CI: 0.226-0.790) were less likely to be successfully treated compared to younger and new cases, respectively. In multinomial logistic regression, age increment by 1 year increased the risk of death and default of TB patients by 0.05 (adjusted β = 0.05; 95% CI: 0.03, 0.06) and 0.02 (adjusted β = 0.02; 95% CI: 0.01, 0.04). The odds of TB patients who died during treatment were higher among HIV-infected TB patients (adjusted β = 2.65; 95% CI: 1.28, 5.50). conclusion: The treatment success rate of TB patients was low as compared to the national target. TB control needs to be strengthened for the enhancement of treatment outcome.
Keywords: tuberculosis, asella, outcomes, smear-positive pulmonary tuberculosis, smear-negative pulmonary tuberculosis inTrODUcTiOn Tuberculosis (TB) remains a major global health problem and has replaced HIV as the leading cause of death from a single infectious agent in 2016 (1) . In 2015, an estimated of 10.4 million people developed TB and 1.4 million died from the disease, 0.4 million of whom were HIV-infected (2) . In absence of appropriate treatment, TB mortality rate remains high (3, 4) . Study on the natural history of TB indicated that up to 70% of smear-positive and 20% of smear-negative cases of pulmonary TB died within 10 years if patients remain untreated (5) . Cognizant of this fact, World Health Organization (WHO) introduced Directly Observed Treatment Short-course (DOTS) strategy in the early 1990s, with the target to cure 85% of newly detected cases of sputum smear-positive TB and to detect 70% of the estimated incidence of sputum smear-positive TB (6, 7) .
In Ethiopia, DOTS program was implemented in 1992 as a pilot in Arsi and Bale Zones of Oromia Region (8) . The program had been subsequently scaled up throughout the country and implemented at national level. According to Federal Ministry of Health assessment in 2013/2014, DOTS program physical coverage reached 98.4% in hospitals and 79% health centers in the country (9) . Nevertheless, different reports across the country have indicated the existence of challenges in treatment outcomes of TB patients despite the implementation of DOTS program (10, 11) . Poor treatment-seeking behavior, incomplete treatment or poor compliance, treatment interruption, or default, a phenomenon that contributes to prolonged infectiousness and a higher risk of drug resistance, relapsed TB, and death, are the major challenges in DOTS program especially in resource-limited settings (12) .
In this study, we aimed to evaluate the treatment outcomes of TB between September 2004 and July 2014 under DOTS program at Asella Teaching Hospital (ATH) in Ethiopia, East African country with TB incidence of 191/100,000 population (2). This hospital was selected because it was one of the first clinical centers that implement DOTS program in Ethiopia, and it has been the only referral hospital in Arsi Zone, serving a large population of approximately 3.5 million, allowing it to best reflect the effectiveness of the DOTS in TB control in the country. The findings also led to the identification of risk factors that are associated with poor treatment outcomes in the current setting. To the best of our knowledge, this is the first and most comprehensive study that specifically addressed the treatment outcome of TB and associated risk factors under DOTS strategy in this public hospital.
MaTerials anD MeThODs study area
Asella Teaching Hospital is University hospital of the newly founded Arsi University, situated in Asella Town, South-East of Addis Ababa. The hospital has 297 beds and acts as a medical referral center for a population of 3.5 million inhabitants in the Arsi Zone and its surroundings. In the hospital, there is one DOTS clinic which has been operating as per National TB and Leprosy Control Program (NTLCP) guideline of Ethiopia. Currently, the clinic provides basic treatment and diagnostic service for all forms of TB through clinical examination, ZiehlNielsen staining method for acid-fast bacilli (AFB)/or auramine O-stained sputum smears examination by light-emitting diodes microscopy and chest radiographs. Patients diagnosed with TB were registered and treated according to the national TLCP guideline (8) . The DOTS clinic is one of the outpatient clinics of Asella Hospital and the hospital has also isolated rooms for inpatients. Though the hospital provides service for a large number of TB patients per year, the data included in this study, however, is collected from those patients who had complete information registered as per the WHO and national tuberculosis guidelines and comprises the variables included for this study (see next section). All TB patients who had complete information according to the aforementioned guidelines were included in this study.
study Design, Period, and Data collection Institutional-based retrospective cross-sectional study was conducted. Treatment outcome of all TB patients registered between September 1, 2004, and July 28, 2014, at DOTS clinic of the Asella Hospital were considered as a source of data for investigation. Registered data with complete information were collected retrospectively by trained health professionals using a structured checklist. The registration logbooks were reviewed for basic information such as patient's age, sex, date of treatment started, date of treatment completed, the address of patients, HIV serostatus, type of TB cases, and treatment outcome.
case and Treatment Definitions
Following the standard practices in Asella Hospital, referral or other patients visiting the health facility are preliminary screened at the triage and directed to the physician. After detailed physical examination, patients with presumptive of pulmonary TB are directed to TB diagnostic laboratory. Accordingly, the patients are categorized as a case of smear-positive pulmonary TB if at least one of the two sputum specimens are positive for AFB microscopy, and chest radiographic abnormalities consistent with active pulmonary TB. The patient is categorized as smear-negative TB if at least two sputum smear examinations were negative for AFB on different occasions in whom chest radiographic abnormalities and clinical findings are consistent with active pulmonary TB, or had the previous history of TB treatment. While the case of extrapulmonary TB (EPTB) is TB of organs other than lungs. Treatment of TB patients depends on age and weight of the patients and the chemotherapeutic indicator Definition Cured -A pulmonary TB patient, who was bacteriologically confirmed by acid-fast bacilli (AFB) microscopy at the beginning of treatment, becomes AFB smear negative or culture-negative in the last month of treatment completion and on at least one previous occasion Treatment success rate -For AFB smear-positive cases, it referred to the percentage of patients who were cured (bacteriologically confirmed by AFB smear) plus who had developed favorable clinical response when treatment is completed among the cases notified to the national health authorities during a specified period. -For AFB smear-negative and EPTB cases, it referred to the percentage of patients who had developed favorable clinical response when treatment is completed among both forms TB cases notified to the national health authorities during a specified period. combination will be decided by the physician. In general, the four drug combination therapy is recommended by the Ethiopian national tuberculosis and leprosy control guideline (8) . For the new TB cases, patient is treated with a combination of isoniazid (H), rifampicin (R), pyrazinamide (P), and ethambutol (E) for the first 2 months' (2RHZE) intensive phase and rifampicin and isoniazid for 4 months of continuation phase (4RH) whereas in retreatment cases streptomycin is also added to the aforementioned combination for the intensive phase, and ethambutol is added to the continuation phase and the continuation period is extended to 5 months.
Definitions Used in This study
Treatment outcome definitions were based on the NTLCP (8) and WHO guidelines (6) as indicated in (Table 1) .
Data Quality assurance
Data were collected after training was given to the data collectors and supervisors. The pretest was done for checklists at Adama Hospital, which is located 75 km away from Asella Hospital. Double data entry was done to Epi-info version 7 to check the consistency.
ethical statement 
Treatment Outcome of smear-Positive TB
According to the national TB control guideline, acid-fast staining is performed for smear-positive pulmonary TB patients under treatment at three different points: at the end of the 2 months' intensive treatment phase, at 5th months during treatment, and at the end of 6th or 8th months to declare that the patient is cured or relapsed (8) . Of the total 480 smear-positive TB patients who had complete information and registered during the study period, 377 (78.5%) were acid-fast staining negative at the end of the treatment phase and on at least one previous occasion. The evaluation of treatment outcome of smear-positive pulmonary TB showed that 377 (78.5%) patients were cured, 21(4.4%) completed the treatment, 35 (7.3%) transferred out to Treatment Outcome of smear negative and extrapulmonary (combined) TB
In the TB clinic of the Asella Hospital, treatment outcomes of any form of TB were registered according to the WHO (13) and national guidelines (8) . As stated in the guidelines, the cure rate is calculated for pulmonary TB with bacteriologically confirmed TB at the beginning of treatment who turns negative in the last months of treatment. Consequently, the cure rate was not calculated for EPTB and smear-negative pulmonary TB. 
TB Treatment success and associated Factors
The treatment success rates were 82.9, 78.6, and 83.9% for smearpositive, smear negative, and EPTB, respectively. Overall, 1,434 (81.7%) were successfully treated for all forms of TB. The proportion of treatment success decline as the age of the TB patients increases ( Table 6 ). Sociodemographic and other clinical related factors in relation to TB treatment outcome were analyzed by bi-variable and multivariable logistic regression model. In the binary logistic regression model, the proportion of TB patients had unsuccessful treatment outcome varied by age group and treatment category. TB patients in old age (AOR = 0.386, 95% CI: 0.250-0.596) and retreatment cases (AOR = 0.422, 95% CI: 0.226-0.790) were less likely to be successfully treated compared to young and new TB cases, respectively ( Table 6) .
Multinomial logistic regression fitted to the recorded factors revealed that age of the patient, type of TB cases, and HIV infectivity were associated with TB treatment outcome. Accordingly, an increment of age by 1 year increased the risk of death of TB patients by 0.05 (adjusted β = 0.05; 95% CI: 0.03, 0.06) and increased the risk of treatment default of TB patients by 0.02 (adjusted β = 0.02; 95% CI: 0.01, 0.04) at the time of treatment.
The odds of TB patients who died during treatment were higher among HIV-infected patients (adjusted β = 2.65; 95% CI: 1.28, 5.50) ( Table 7) .
DiscUssiOn
Recommendations on how to evaluate treatment outcomes using standardized categories have been issued by the WHO in conjunction with the European Region of the International Union Against TB and Lung Disease (14) . This would make it possible to recognize and amend failures of the system before the incidence and proportion of TB and resistant isolates rise. This study aimed to assess the aggregate 10 years DOTS strategybased treatment outcomes at Asella Hospital, which is the first hospital in the country selected to pilot the strategy (15) .
The relatively higher proportion TB in male (53.8%) in this retrospective data is in agreement with the study conducted elsewhere (10, (16) (17) (18) , which could be related to the underutilization of health facility by female patients that could intern be due to various socioeconomic and cultural influences as suggested by Mohammed et al. (16) or could also be due to the real biological differences between male and female in susceptibility to development of active disease (19) .
The overall 5.5% defaulter rate in this study is close to 5% global target by WHO (13) but lower than the 15 years average default rate of 8.6% of Arsi Zone (15) and 5 years average default rate of 18.3% from Gondar University Teaching Hospital in North West Ethiopia (20) and 9.8% from a study done in South Africa (16) . The lower defaulter rate in this study might be due to the deployment of health extension workers (HEWs) in the community which aimed to deliver selected high impact packages of curative and preventive interventions at the community level in all zones in Ethiopia (21) . The presence of strict and continuous absentees tracing practice in the community by the HEWs has significantly reduced the number TB defaulters (9) .
Treatment failure is the major threat to the control of TB as these patients are at higher risk of developing drug-resistant TB and often associated with poor retreatment outcome (22) . The average treatment failure rate of 0.2% in this study is consistent with 0.2% (95% CI: 0.19%, 0.20%) by Mesay et al. (23), 0.4% (95% CI: 0.26%, 0.59%) by Belete et al. (24), 0.5% (95% CI: 046%, 0.53%) by Fantahun et al. (25) , and 0.5% (95% CI: 0.49%, 0.51) by Shallo et al. (15) . The lower treatment failure in this study could be related to the higher smear conversion rate of smearpositive pulmonary TB at the end of the intensive treatment phase which is the single most significant predictor of the TB treatment failure (26) that could also be potentially linked to the low drug resistance rate in the area (27) .
Mortality due to TB is one of the major grave treatment outcomes and that could be associated with different comorbidities (28) . In this study, the average 6% (CI: 4.91%, 7.19%) mortality rate is close to 7.4% (CI: 6.97%, 7.83%) reported by Shallo et al. (15) . from Arsi Zone and lower than 10% (CI: 9.20%, 11.07%) reported by Belay et al. (20) . from Gondar University Teaching Hospital, and 13.6% (CI: 11.69%, 15.65%) recorded in South Africa by Mohammed et al. (16) . As in the case reported by Belay et al. (20) , Lee et al. (29) , and Süreyya et al. (30) , the death rate in our study is higher in older and retreatment TB patients. A study conducted in Arsi Zone (15) reported average treatment success rate of 83.6% which is comparable to our current finding of 81.7%. The current treatment success rate; however, is lower than the national average of 92.1% for the year 2014/15 for new bacteriologically confirmed PTB cases (31) and 85% treatment success target by WHO (32) . On the other hand, our result is higher when compared to similar studies done in North Western part of Ethiopia (20, 25) . The higher treatment success rate in our finding than studies from North West of Ethiopia might be due to the high proportion of transfer outpatients in those studies where it was not possible to identify the treatment outcomes of transferred outpatients.
The higher treatment success rate in the younger age group is in agreement with the report from elsewhere (15, (33) (34) (35) . Older individuals often have concomitant diseases, general physiological deterioration with age, less able to reach health facilities and are also poorer than the younger population (36) . Retreatment cases (AOR = 0.422, 95% CI: 0.226-0.790) in comparison with new TB cases were less likely to be successfully treated. This is consistent with a study conducted in Arsi zone of Ethiopia (15), Northern part of Ethiopia (35) , and South Africa (16) . This might be due to the high chance of MDR-TB among previously treated patients than new TB cases (37).
In multinomial logistic regression, an increment of age by 1 year increased the risk of death of TB patients by 0.05. This might be related to the gradual loss of competent immune response (38) , which might increase the risk of death if individual caught TB in their late age (39) . On the other hand, an increment of age by 1 year increased the risk of default of TB patients by 0.02. The possible explanation might be linked to the fact that in young age, families/or guardian may give due emphasis for their child to adhere to TB treatment; however, as the age increase, they become independent to decide by themselves which might give less attention to treatment adherence. At a late age, the increased risk of defaulter rate might be due to physiological deterioration, inability to reach physically to health facilities and poor socioeconomic status than the younger population.
Our findings revealed that the odds of having TB patients who died during treatment were higher among HIV-infected patients. This is similar to WHO report for African region but lower than global report where the death rate of TB patients among HIV positive was higher than HIV-negative TB patients (11 vs 3.4%) (13) . Our finding is also in agreement with the study from South Africa (40) where they indicated a strong association between HIV infection and mortality due to TB. This indicates further efforts are needed to strengthen the recommended WHO TB/ HIV collaborative activities at all level of the health care delivery system. Based on our findings, to enhance the favorable TB treatment outcomes and strengthen the control efforts, we suggest the following points to be considered: following the current WHO End TB strategy direction (1), focusing on addressing the challenges in defaulters and promoting adherence (involving families and communities) should be deliberated. Early diagnosis of TB including universal drug-susceptibility testing and systematic screening of contacts and high-risk groups and collaborative TB/HIV activities, and management of comorbidities are recommended.
Our report has also some limitations. We conducted a retrospective study to assess the treatment outcomes and associated risk factors of TB patients at Asella Hospital. Thus, it could not be possible to establish the causal relationship between the predictors and the outcome variables. Data were also collected from old TB registration books which contained inaccurate and incomplete information about patients. Therefore, we could not claim that this could be free of selection bias. It was also not possible to conduct the drug-susceptibility test on failed cases. Moreover, due to a limitation in obtaining the data of TB patients during the pre-DOTS period, the assessment of the effectiveness of its strategy could not be best achieved by the current research only and the different categories of EPTB was not available from the registration book.
In conclusion, the overall treatment success is lower than the national target and goal set by WHO. Age and comorbidities are the major predictors of unfavorable treatment outcomes. TB control needs to be strengthened for the enhancement of treatment outcome.
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